EDITAS MEDICINE, INC. Earnings Per Share (Basic)
EDITAS MEDICINE, INC. (EDIT) reported Earnings Per Share (Basic) of -$0.15 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-05
- EDITAS MEDICINE, INC. earnings per share, basic for the quarter ending 2026-06-30 was -$0.15.
- EDITAS MEDICINE, INC. earnings per share, basic for the quarter ending 2026-03-31 was -$0.26.
- EDITAS MEDICINE, INC. earnings per share, basic for the quarter ending 2025-09-30 was -$0.28.
- EDITAS MEDICINE, INC. earnings per share, basic for the quarter ending 2025-06-30 was -$0.63.
- EDITAS MEDICINE, INC. earnings per share, basic for fiscal 2025 was -$1.80.
- EDITAS MEDICINE, INC. earnings per share, basic for fiscal 2024 was -$2.88.
- EDITAS MEDICINE, INC. earnings per share, basic for fiscal 2023 was -$2.02.
- EDITAS MEDICINE, INC. earnings per share, basic for fiscal 2022 was -$3.21.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$0.15 10-Q · filed 2026-08-05 | -$0.40 10-Q · filed 2026-08-05 | ||
| 2026-03-31 | -$0.26 10-Q · filed 2026-05-05 | |||
| 2025-12-31 | -$1.80 10-K · filed 2026-03-09 | |||
| 2025-09-30 | -$0.28 10-Q · filed 2025-11-10 | -$1.80 10-Q · filed 2025-11-10 | ||
| 2025-06-30 | -$0.63 10-Q · filed 2026-08-05 | -$1.54 10-Q · filed 2026-08-05 | ||
| 2025-03-31 | -$0.92 10-Q · filed 2026-05-05 | |||
| 2024-12-31 | -$2.88 10-K · filed 2026-03-09 | |||
| 2024-09-30 | -$0.75 10-Q · filed 2025-11-10 | -$2.33 10-Q · filed 2025-11-10 | ||
| 2024-06-30 | -$0.82 10-Q · filed 2025-08-12 | -$1.58 10-Q · filed 2025-08-12 | ||
| 2024-03-31 | -$0.76 10-Q · filed 2025-05-12 | |||
| 2023-12-31 | -$2.02 10-K · filed 2025-03-05 | |||
| 2023-09-30 | -$0.55 10-Q · filed 2024-11-04 | -$1.81 10-Q · filed 2024-11-04 | ||
| 2023-06-30 | -$0.56 10-Q · filed 2024-08-07 | -$1.27 10-Q · filed 2024-08-07 | ||
| 2023-03-31 | -$0.71 10-Q · filed 2024-05-08 | |||
| 2022-12-31 | -$3.21 10-K · filed 2025-03-05 | |||
| 2022-09-30 | -$0.81 10-Q · filed 2023-11-03 | -$2.33 10-Q · filed 2023-11-03 | ||
| 2022-06-30 | -$0.78 10-Q · filed 2023-08-02 | -$1.52 10-Q · filed 2023-08-02 | ||
| 2022-03-31 | -$0.74 10-Q · filed 2023-05-05 | |||
| 2021-12-31 | -$2.85 10-K · filed 2024-02-28 | |||
| 2021-09-30 | -$0.57 10-Q · filed 2022-11-02 | -$2.24 10-Q · filed 2022-11-02 | ||
| 2021-06-30 | -$0.81 10-Q · filed 2022-08-03 | -$1.67 10-Q · filed 2022-08-03 | ||
| 2021-03-31 | -$0.86 10-Q · filed 2022-05-04 | |||
| 2020-12-31 | -$1.00 10-K · filed 2021-02-26 | -$0.88 derived: net income ÷ weighted average shares · filed 2023-02-22 | -$1.31 derived: net income ÷ weighted average shares · filed 2023-02-22 | -$1.98 10-K · filed 2023-02-22 |
| 2020-09-30 | $0.13 10-Q · filed 2021-11-09 | -$0.27 derived: net income ÷ weighted average shares · filed 2021-11-09 | -$0.93 10-Q · filed 2021-11-09 | -$1.63 derived: net income ÷ weighted average shares · filed 2022-02-24 |
| 2020-06-30 | -$0.43 10-K · filed 2021-02-26 | -$1.12 derived: net income ÷ weighted average shares · filed 2021-08-05 | -$1.83 derived: net income ÷ weighted average shares · filed 2022-02-24 | -$2.49 derived: net income ÷ weighted average shares · filed 2022-02-24 |
| 2020-03-31 | -$0.69 10-K · filed 2021-02-26 | -$1.41 derived: net income ÷ weighted average shares · filed 2022-02-24 | -$2.08 derived: net income ÷ weighted average shares · filed 2022-02-24 | |
| 2019-12-31 | -$0.72 derived: net income ÷ weighted average shares · filed 2022-02-24 | -$1.39 derived: net income ÷ weighted average shares · filed 2022-02-24 | -$2.68 10-K · filed 2022-02-24 | |
| 2019-09-30 | -$0.66 10-Q · filed 2020-11-06 | -$1.95 10-Q · filed 2020-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |